IPA+CJC is a research combination pairing Ipamorelin (a selective GH secretagogue) with CJC-1295 (a GHRH analog), creating a dual-action tool for investigating growth hormone axis stimulation. Ipamorelin selectively activates the ghrelin receptor to induce GH release with minimal effects on cortisol or prolactin, while CJC-1295 prolongs GHRH signaling. Together, they are studied for synergistic effects on GH pulse amplitude, IGF-1 elevation, lean mass signaling, and anti-aging biomarkers in preclinical models. PeptideBull provides IPA+CJC at research-grade purity. Not intended for human or veterinary use.
Related Products
